![Mark Glickman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Glickman
Directeur/Membre du Conseil chez
METAVIA INC.
Fortune : 9 778 $ au 31/05/2026
Profil
Mark A. Glickman is President & Chief Executive Officer at BioFlorida, Inc. since 2023.
He is Director at Otsuka Precision Health, Inc. starting in 2024.
He serves as Independent Director at MetaVia, Inc. since 2023 and at BioStem Technologies, Inc. beginning in 2026.
Formerly, Mr. Glickman was Co-CEO & Chief Business Officer at TherapeuticsMD, Inc. from 2022 to 2023.
He was Marketing Director & Vice President-Sales at KOS Pharmaceuticals, Inc. from 2001 to 2007.
He held the position of General Manager-Sales at Baxter Healthcare Corp.
from 1989 to 1995.
He served as Senior Vice President-Sales & Marketing at Oscient Pharmaceuticals Corp.
from 2007 to 2009.
He was Chief Commercial Officer at Esperion Therapeutics, Inc. from 2018 to 2020.
He held the role of Chief Commercial Officer at POZEN, Inc. from 2015 to 2016.
He was Senior Vice President-Sales at Auxilium Pharmaceuticals LLC from 2012 to 2015.
He was Vice President-Sales at Bayer HealthCare.
He served as Vice President-Medical Device Division at Otsuka America Pharmaceutical, Inc. from 2009 to 2012.
He was Chief Commercial Officer at Old API Wind-down Ltd. from 2015 to 2018.
Education includes undergraduate studies at State University of New York College at Oswego and an MBA from NYU Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
METAVIA INC. 0,07 % | 08/06/2026 | 3 443 ( 0,07 % ) | 9 778 $ | 31/05/2026 |
Postes actifs de Mark Glickman
| Sociétés | Poste | Début |
|---|---|---|
| METAVIA INC. | Directeur/Membre du Conseil | 11/05/2023 |
| BIOSTEM TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 05/06/2026 |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Directeur Général | 09/12/2023 |
Anciens postes connus de Mark Glickman
| Sociétés | Poste | Fin |
|---|---|---|
| THERAPEUTICSMD, INC. | Directeur Général | 01/01/2023 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 11/12/2020 |
| OLD API WIND-DOWN LTD. | Corporate Officer/Principal | 30/03/2018 |
| POZEN INC. | Corporate Officer/Principal | 01/02/2016 |
| AUXILIUM PHARMACEUTICALS, INC. | Sales & Marketing | 01/03/2015 |
Formation de Mark Glickman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
State University of New York College at Oswego
 State University of New York College at Oswego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare /Diabetes Care Division/
 Bayer HealthCare /Diabetes Care Division/ Medical DistributorsDistribution Services Provides diabetes care products | Distribution Services |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Commercial Services |
BioStem Technologies, Inc.
 BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
TherapeuticsMD, Inc.
 TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
